I for one am throughly disappointed in this and am wondering if I should go ahead and cut my losses and leave. The so called DTC campaign so far seems like a farce. Internet marketing is barely a $500K cost.
I really think Sanofi is trying to bury Mannkind. What puzzzles me is why Mannkind managment is not demanding meetings with Sanofi management to address these issues.
If you have a partner, you should expect the partner to conduct their part of the bargain. So far Sanofi has not done this! Maybe Al needs to call Bandicourt himself. This has to be painful to Al Mann.
So I find it intriguing that Matt quote sin the LA times today :
“Advertising and new Internet-based marketing efforts did not begin until this quarter, so their effects have not yet been seen,”
My question is: DOES Matt and the rest of Mannkind know that the average spend for internet marketing and a social media campaign is usually less that $400K. Add the Time magazine (one time ad) at maybe $100K and the DTC effort so far is less that $1/2Million?????
$1/2 Million ad spend for a DRUG that took 10 years to make and cost them a $1Billion?
I am starting to think SANOFI is taking them for a LOBOTOMY!!
NO wonder scripts are not up!!!
supposedly there's an ad in time magazine, but that's about it.
Kind of hokey if you ask me as I would expect and demand more if I was Mannkind. Especially from Sanofi!!
they are capable of launching and marketing a product, an example is Toejeo which was launched afterAfrezza and yet has more sales.
I am really ANNOYED at Mannkind!
there is no other choice unfortunately. the time for polite email to them is gone and the time for them to get their asssssssesssss in gear and call out sanofi is NOW!
yes I realize this has been a hurting investment for so long, everyone must be prepared to lose it all. (Even -Al Mann)
And if I do, I will curse the day, yet, I will have tried!
so Gino, please tell me what you see. why do you see this as a negative?
They are RETIRING the debt that was an overhang. Now BOA who had the notes EXCLUSIVELY for SHORTING, will not be able to do so. The shares that end up being issued will NOT BE used for SHORTING.
All in all, not bad!
1. we get our 9M shares back from BOA, SO they CANNOT be SHORTED!
2. We issue 9M+possibly a max of 3M shares - SO THEY CANNOT BE SHORTED. BOA (or whoever becomes A LONG)
3. dilution - Max 3M shares
4. BALANCE SHEET - Much BETTER!
5. IF PRICE GOES UP in 10 days less shares issued
6. Filing 1 day before SANOFI REPORTS
me thinks they are expecting PRICE to JUMP!
I am starting to the think the real short is AL MANN himself! No disrespect, but what GIVES ????
If he wanted to take it private why not try and get rid of us PESKY long term holders???
Here's my questions:
Dear Mr Pfeffer,
As a minority shareholder, I am a bit annoyed at the lack of movement and the constant barrage of negativity surrounding Mannkind. You weekly and monthly sales numbers being reported at IMS and Symphony are not even close to Exhubera's numbers, yet Mannkind continues to state they are "on the brink" of good sales. What gives? Sanofi, except for the one advertisement has not really stepped up to the plate in marketing Afrezza. A DTC capmapign was to be started in early July and yet we hear nothing? A third production line was supposed to be approved and running for 12 unit cartridges and yet nothing? the convertible debt issue was to be resolved and yet us minority shareholders have no direction on how the company will do this? Sanofi has partnershiped with Mannkind almost an entire year ago and was sucessful in getting EU and US approval for Toujeo and has significant #s being reported and yet Toujeo was approved and launched way after Afrezza? I realize you will have to report on these and other matters going on in Mannkind but yet no announcement on your earnings date?
As I'm sure you know, without an agressive campaign to market the product, it is still unknown mostly, and we are now approaching the one year anniversary of the partnership deal with Sanofi and almost one and a half years since Afrezza was approved. A lot of people have a lot of money invested in Mannkind due to the novel approach, and the fact that it us ultra rapid acting. Yet no timeline for label change?
many variables incipient in last post, but you get the idea. Shorts are screwed, and they know it, hold tight, fun begins soon
chill all. A 50% short position at current MC equates to a billion dollar investment on the wrong side. Longs already won. Just time.
Agreed. Sanofi signed a deal to market MNKD with the label it received. Relying on the FDA to better the label, although very much possible, is not in the best interest of Mannkind or Sanofi for that matter.
frankly I don't think Sam is paid, and I also don't think Amy is paid. I simply think she's bipolar.
AF on the other hand is PAID
Sam just did to Adam what Al did to Adam a few years ago ...........!!!!!!!
I just can't say it on the YAHOO board!! LMAO!